Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | TNF | P01375 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23106599 | 0.98 | PTPN1 (0.47) | PTPN1CYP1A2CASP3EPHX2TNF | |
| SCHEMBL23106467 | 0.98 | PTPN1 (0.47) | PTPN1CYP1A2CASP3EPHX2TNF | |
| SCHEMBL31559098 | 0.93 | CASP3 (0.51) | PTPN1CYP1A2CASP3CTSK | |
| SCHEMBL31217961 | 0.89 | CASP3 (0.51) | PTPN1CASP3EPHX2KMT2A | |
| SCHEMBL29270865 | 0.88 | CTSL (0.55) | PTPN1CASP3KMT2ACTSK | |
| SCHEMBL29270866 | 0.88 | CTSL (0.55) | PTPN1CASP3KMT2ACTSK | |
| SCHEMBL31214742 | 0.88 | LMNA (0.52) | CYP1A2KMT2ACTSK | |
| SCHEMBL30715210 | 0.87 | CASP3 (0.47) | PTPN1CASP3CTSK | |
| SCHEMBL31217786 | 0.87 | CASP3 (0.49) | PTPN1CASP3EPHX2KMT2A | |
| SCHEMBL31217931 | 0.87 | CASP3 (0.49) | PTPN1CASP3EPHX2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024235132-A9 | COMPOUND HAVING BIOLOGICAL ACTIVITY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2025-06-19 | — | — | WO | disclosed |
| WO-2024235128-A9 | ANTIBODY-DRUG CONJUGATE AND PREPARATION METHOD AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2025-06-19 | — | — | WO | disclosed |
| WO-2024235132-A1 | COMPOUND HAVING BIOLOGICAL ACTIVITY, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-11-21 | — | — | WO | disclosed |
| WO-2024235128-A1 | ANTIBODY-DRUG CONJUGATE AND PREPARATION METHOD AND USE THEREOF | 四川科伦博泰生物医药股份有限公司 | 2024-11-21 | — | — | WO | disclosed |